Mind Medicine (MNMD) Stock May Take Time To Cross $4: Here is The Plan

On Thursday, psychedelics based medicine developer Mind Medicine Inc (NASDAQ:MNMD) announced the results from its shareholders meeting and that might have triggered the 4% jump in the company’s stock price this morning.

Mind Medicine (MNMD) Stock May Take Time To Cross $4: Here is The Plan

The company announced yesterday that all the resolutions that were put forward at the shareholder’s meeting were passed by the necessary majority. The company published a press release yesterday in which it laid out the resolutions that were passed by the shareholders.

Mind Medicine announced the names of the personnel who were re-elected as directors in the company. In addition to that, the resolution to fix the number of directors at the company to only 7 was approved by the shareholders as well. More importantly, all the seven nominees who were put forward by Mind Medicine were approved at the meeting. The passing of all these resolutions is an important development for Mind Medicine and it could be interesting to see if it can bring some momentum to the stock or not.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.